Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $744.66 ($74K) on 2023-08-01, disclosed to the SEC on 2023-08-03.
Scheduled sale ($74k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $732.76 | 2 | $1K | 2.0% |
| 2 | $733.51 | 4 | $3K | 4.0% |
| 3 | $734.56 | 18 | $13K | 18.0% |
| 4 | $735.55 | 22 | $16K | 22.0% |
| 5 | $736.64 | 16 | $12K | 16.0% |
| 6 | $737.50 | 17 |
| $13K |
| 17.0% |
| 7 | $738.45 | 10 | $7K | 10.0% |
| 8 | $739.63 | 5 | $4K | 5.0% |
| 9 | $740.52 | 3 | $2K | 3.0% |
| 10 | $741.42 | 2 | $1K | 2.0% |
| 11 | $744.66 | 1 | $745 | 1.0% |
| Total | $736.59 avg | 100 | $74K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |